Literature DB >> 33186470

Altered circadian activity and sleep/wake rhythms in the stable tubule only polypeptide (STOP) null mouse model of schizophrenia.

Samuel Deurveilher1, Kristin Robin Ko2, Brock St C Saumure1, George S Robertson3,4, Benjamin Rusak3,5, Kazue Semba1,3,5.   

Abstract

Sleep and circadian rhythm disruptions commonly occur in individuals with schizophrenia. Stable tubule only polypeptide (STOP) knockout (KO) mice show behavioral impairments resembling symptoms of schizophrenia. We previously reported that STOP KO mice slept less and had more fragmented sleep and waking than wild-type littermates under a light/dark (LD) cycle. Here, we assessed the circadian phenotype of male STOP KO mice by examining wheel-running activity rhythms and EEG/EMG-defined sleep/wake states under both LD and constant darkness (DD) conditions. Wheel-running activity rhythms in KO and wild-type mice were similarly entrained in LD, and had similar free-running periods in DD. The phase delay shift in response to a light pulse given early in the active phase under DD was preserved in KO mice. KO mice had markedly lower activity levels, lower amplitude activity rhythms, less stable activity onsets, and more fragmented activity than wild-type mice in both lighting conditions. KO mice also spent more time awake and less time in rapid eye movement sleep (REMS) and non-REMS (NREMS) in both LD and DD conditions, with the decrease in NREMS concentrated in the active phase. KO mice also showed altered EEG features and higher amplitude rhythms in wake and NREMS (but not REMS) amounts in both lighting conditions, with a longer free-running period in DD, compared to wild-type mice. These results indicate that the STOP null mutation in mice altered the regulation of sleep/wake physiology and activity rhythm expression, but did not grossly disrupt circadian mechanisms. © Sleep Research Society 2020. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please e-mail journals.permissions@oup.com.

Entities:  

Keywords:  EEG/EMG recording; MAP6; activity fragmentation; circadian rhythms; constant darkness; light-induced phase shift; light/dark cycle; microtubule-associated protein; transgenic mice; wheel-running activity

Mesh:

Substances:

Year:  2021        PMID: 33186470      PMCID: PMC8033464          DOI: 10.1093/sleep/zsaa237

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  74 in total

1.  Nitric oxide synthase mediates the ability of darbepoetin alpha to improve the cognitive performance of STOP null mice.

Authors:  Kosuke Kajitani; Michael Thorne; Michel Samson; George S Robertson
Journal:  Neuropsychopharmacology       Date:  2010-03-24       Impact factor: 7.853

2.  Influence of running wheel activity on free-running sleep/wake and drinking circadian rhythms in mice.

Authors:  D M Edgar; T S Kilduff; C E Martin; W C Dement
Journal:  Physiol Behav       Date:  1991-08

Review 3.  Feedback actions of locomotor activity to the circadian clock.

Authors:  Alun T L Hughes; Hugh D Piggins
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

4.  Actigraphic estimates of circadian rhythms and sleep/wake in older schizophrenia patients.

Authors:  J Martin; D V Jeste; M P Caliguiri; T Patterson; R Heaton; S Ancoli-Israel
Journal:  Schizophr Res       Date:  2001-01-15       Impact factor: 4.939

5.  Sleep homeostasis in the rat is preserved during chronic sleep restriction.

Authors:  Susan Leemburg; Vladyslav V Vyazovskiy; Umberto Olcese; Claudio L Bassetti; Giulio Tononi; Chiara Cirelli
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

6.  Microtubule-associated STOP protein deletion triggers restricted changes in dopaminergic neurotransmission.

Authors:  Caroline Bouvrais-Veret; Stéphanie Weiss; Naima Hanoun; Annie Andrieux; Annie Schweitzer; Didier Job; Michel Hamon; Bruno Giros; Marie-Pascale Martres
Journal:  J Neurochem       Date:  2008-02       Impact factor: 5.372

7.  The FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomes.

Authors:  Benjamin M Schwenk; Christina M Lang; Sebastian Hogl; Sabina Tahirovic; Denise Orozco; Kristin Rentzsch; Stefan F Lichtenthaler; Casper C Hoogenraad; Anja Capell; Christian Haass; Dieter Edbauer
Journal:  EMBO J       Date:  2013-12-19       Impact factor: 11.598

8.  MAP6 interacts with Tctex1 and Cav 2.2/N-type calcium channels to regulate calcium signalling in neurons.

Authors:  Jacques Brocard; Fabrice Dufour; Sylvie Gory-Fauré; Christophe Arnoult; Christophe Bosc; Eric Denarier; Leticia Peris; Yasmina Saoudi; Michel De Waard; Annie Andrieux
Journal:  Eur J Neurosci       Date:  2017-11-22       Impact factor: 3.386

Review 9.  Repositioning Microtubule Stabilizing Drugs for Brain Disorders.

Authors:  Artemis Varidaki; Ye Hong; Eleanor T Coffey
Journal:  Front Cell Neurosci       Date:  2018-08-08       Impact factor: 5.505

10.  Diurnal rhythms in gene expression in the prefrontal cortex in schizophrenia.

Authors:  Marianne L Seney; Kelly Cahill; John F Enwright; Ryan W Logan; Zhiguang Huo; Wei Zong; George Tseng; Colleen A McClung
Journal:  Nat Commun       Date:  2019-08-09       Impact factor: 14.919

View more
  1 in total

1.  The circadian system in cystic fibrosis mice is regulated by histone deacetylase 6.

Authors:  Eric Barbato; Rebecca Darrah; Thomas J Kelley
Journal:  Am J Physiol Cell Physiol       Date:  2022-09-05       Impact factor: 5.282

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.